Antibiotic Resistance Is the Quiet Public-Health Emergency
Resistant infections kill more people yearly than road accidents, and the R&D pipeline for new antibiotics is nearly empty.
An innovation-market failure
Antibiotics are used briefly and priced cheaply, so pharma has little incentive to develop them — a market failure with lethal consequences.
Push-pull mechanisms like subscription payments are finally funding the pipeline, but stewardship (using less) and new classes must arrive before the last lines of defence fail.
FAQs
What is "Antibiotic Resistance Is the Quiet Public-Health Emergency" about?
Resistant infections kill more people yearly than road accidents, and the R&D pipeline for new antibiotics is nearly empty.
Who wrote "Antibiotic Resistance Is the Quiet Public-Health Emergency"?
"Antibiotic Resistance Is the Quiet Public-Health Emergency" was written by Demo Admin. Building incoffeed — a daily editorial on tech, AI, fintech and business. Co-founder & editor.
How long does it take to read "Antibiotic Resistance Is the Quiet Public-Health Emergency"?
8 min — that's the estimated reading time for "Antibiotic Resistance Is the Quiet Public-Health Emergency" at an average pace.
Where can I find more stories like "Antibiotic Resistance Is the Quiet Public-Health Emergency"?
More Biotech & Health coverage lives under the “Biotech & Health” topic on incoffeed. You can also react to this story and join the discussion below — the feed keeps serving related reads as you scroll.